A study using human HCC cell lines, including HepG2 and Hep3B, showed that inhibition of MAP4K4 decreases HCC cell growth by inhibiting cellular proliferation and inducing cellular apoptosis. This evidence concerns the gene MAP4K4 and hepatocellular carcinoma.